Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AGIO

Agios Pharmaceuticals Inc

May 06 • 04:00PM ET

26.98

-0.23 -0.85 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: AMGN REGN VRTX GILD ALNY SRPT NBIX BLUE FOLD NVAX

| Held by: VTI XBI VB IWM VBK VXF IWN IBB VTWO SCHA

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-7.25	Insider Own	8.50%	Shs Outstand	59.34M	Perf Week	-3.81%
Market Cap	1.60B	Forward P/E	-	EPS next Y	-4.68	Insider Trans	-2.21%	Shs Float	54.41M	Perf Month	-23.16%
Enterprise Value	903.24M	PEG	-	EPS next Q	-1.61	Inst Own	104.74%	Short Float	13.02%	Perf Quarter	-2.60%
Income	-422.60M	P/S	24.29	EPS this Y	13.91%	Inst Trans	-6.97%	Short Ratio	6.61	Perf Half Y	-32.77%
Sales	66.05M	P/B	1.44	EPS next Y	23.68%	ROA	-30.84%	Short Interest	7.08M	Perf YTD	-0.88%
Book/sh	18.69	P/C	2.18	EPS next 5Y	23.25%	ROE	-32.82%	52W High	46.00 -41.35%	Perf Year	-4.73%
Cash/sh	12.39	P/FCF	-	EPS past 3/5Y	-18.95% -8.46%	ROIC	-37.53%	52W Low	22.24 21.31%	Perf 3Y	5.64%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	55.97% -	Gross Margin	82.07%	Volatility	3.88% 4.60%	Perf 5Y	-51.03%
Dividend TTM	-	EV/Sales	13.68	EPS Y/Y TTM	-161.91%	Oper. Margin	-719.97%	ATR (14)	1.55	Perf 10Y	-38.09%
Dividend Ex-Date	-	Quick Ratio	13.59	Sales Y/Y TTM	78.34%	Profit Margin	-639.84%	RSI (14)	41.92	Recom	1.60
Dividend Gr. 3/5Y	- -	Current Ratio	14.19	EPS Q/Q	-8.50%	SMA20	-7.46%	Beta	0.57	Target Price	41.12
Payout	-	Debt/Eq	0.03	Sales Q/Q	137.75%	SMA50	-8.74%	Rel Volume	1.01	Prev Close	27.21
Employees	540	LT Debt/Eq	0.02	Earnings	Apr 29 BMO	SMA200	-18.30%	Avg Volume	1.07M	Price	26.98
IPO	Jul 24, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	6.29% 55.98%	Trades		Volume	1,083,941	Change	-0.85%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)